APP and Alzheimer disease: The authors showed that the absence of ABCB1 results in a significant disturbance of Aβ removal in a transgenic murine model of AD (APP/PS1+/−−ABCB1), leading to an increased intraparenchymal cerebral amyloid angiopathy.